Endometriosis research offers new hope for chronic pain and fertility management

Endometriosis affects approximately one in seven women globally, causing chronic pelvic pain and potential infertility by damaging the ovaries and fallopian tubes. Dr. Abhishek Mangeshikar, director of the Indian Centre for Endometriosis, noted that the condition can involve various organs, including the intestines, bladder, and nerves, often requiring complex multidisciplinary care. In India alone, an estimated 27 million women suffer from the condition, which can significantly impact their career progression and work lives.

Recent research offers a potential breakthrough via a modified version of the anti-parasitic drug niclosamide. To overcome the drug's poor absorption and side effects, scientists have attached it to microscopic water-soluble dendrimers. This targeted delivery system aims to reach disease-causing immune cells. Preclinical trials in mice showed reduced lesion size and lower pain sensitivity. This non-hormonal, non-surgical approach could provide an alternative to current treatments, which often involve invasive surgery or hormone therapies that cause side effects like osteoporosis and depression.